Variant report
Variant | esv3442347 |
---|---|
Chromosome Location | chr4:56557073-56574616 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:56562390..56565132-chr4:56566975..56569939,2 | K562 | blood: | |
2 | chr4:56567077..56569612-chr4:56570589..56573149,3 | K562 | blood: | |
3 | chr4:56563632..56566026-chr4:56568439..56570285,2 | K562 | blood: | |
4 | chr4:56563632..56566026-chr4:56568439..56570285,2 | K562 | blood: | |
5 | chr4:56567077..56569612-chr4:56570589..56573149,3 | K562 | blood: | |
6 | chr4:56571957..56574091-chr4:56598749..56600551,2 | K562 | blood: | |
7 | chr4:56562390..56565132-chr4:56566975..56569939,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375637607 | chr4:56567849-56567850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs567445679 | chr4:56567854-56567855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536211996 | chr4:56567865-56567866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552959647 | chr4:56567866-56567867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556941469 | chr4:56567876-56567877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566778569 | chr4:56567893-56567894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190429389 | chr4:56567917-56567918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537536601 | chr4:56568008-56568009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559019809 | chr4:56568067-56568068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575771337 | chr4:56568072-56568073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs6554305 | chr4:56568075-56568076 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs554611829 | chr4:56568104-56568105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549996519 | chr4:56568145-56568146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376355003 | chr4:56568157-56568158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112077148 | chr4:56568161-56568162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540186670 | chr4:56568206-56568207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181252132 | chr4:56568253-56568254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370591021 | chr4:56568319-56568320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532187828 | chr4:56568454-56568455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35484068 | chr4:56568468-56568469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546065267 | chr4:56568481-56568482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143729852 | chr4:56568508-56568509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6828640 | chr4:56568521-56568522 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs151271121 | chr4:56568535-56568536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576405739 | chr4:56568598-56568599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567384245 | chr4:56568678-56568679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553669434 | chr4:56568732-56568733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571984163 | chr4:56568755-56568756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186607463 | chr4:56568773-56568774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140343911 | chr4:56568774-56568775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566511312 | chr4:56568827-56568828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371913637 | chr4:56568846-56568847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10715958 | chr4:56568847-56568848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113798806 | chr4:56568867-56568868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs397993449 | chr4:56568868-56568869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538682945 | chr4:56568884-56568885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6829328 | chr4:56568889-56568890 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs368127709 | chr4:56568890-56568891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371680975 | chr4:56568936-56568937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371949109 | chr4:56568950-56568951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs6829521 | chr4:56568958-56568959 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs189545197 | chr4:56568965-56568966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553944476 | chr4:56568976-56568977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557898636 | chr4:56568983-56568984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551141345 | chr4:56568999-56569000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545504134 | chr4:56569007-56569008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374953167 | chr4:56569008-56569009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555334595 | chr4:56569012-56569013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs180926802 | chr4:56569037-56569038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186125635 | chr4:56569063-56569064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Glioblastoma | 17504929 | CNVD |
Glioblastoma | 16823502 | CNVD |
Melanoma | 16908931 | CNVD |
Glioblastoma | 20031968 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Gastrointestinal stromal cancer | 17438095 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:56567800-56570200 | Weak transcription | Aorta | Aorta |
2 | chr4:56570600-56571000 | Enhancers | K562 | blood |
3 | chr4:56571000-56573400 | Weak transcription | K562 | blood |
4 | chr4:56572000-56572600 | Enhancers | NHDF-Ad | bronchial |
5 | chr4:56572200-56572800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr4:56572200-56573600 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr4:56572400-56573800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr4:56572600-56573000 | Enhancers | Osteobl | bone |
9 | chr4:56572600-56573200 | Weak transcription | NHDF-Ad | bronchial |
10 | chr4:56572800-56573200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr4:56573200-56573400 | Enhancers | NHDF-Ad | bronchial |
12 | chr4:56573200-56573600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr4:56573400-56574000 | Active TSS | K562 | blood |
14 | chr4:56573600-56574200 | Active TSS | HUES6 Cell Line | embryonic stem cell |
15 | chr4:56573800-56574000 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |